Novel tubulin-targeted cell penetrating antimitotic octapeptide

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Tubulin dynamics are crucial for cell division and motility.
• Disrupting tubulin polymerization is a validated anti-cancer strategy.
• Novel agents targeting tubulin are needed to overcome resistance.

Purpose of the Study:

• To discover and characterize a novel antimitotic cell-penetrating octapeptide.
• To investigate the mechanism of action of this peptide on tubulin and microtubules.
• To evaluate the anti-tumor efficacy of the peptide in a multicellular tumor spheroid model.

Main Methods:

• Synthesis and characterization of the octapeptide.
• Binding assays with tubulin.
• In vitro assays for tubulin polymerization and kinesin motility.
• Western blotting for checkpoint protein activation.
• Assessment of apoptosis induction.
• Multicellular tumor spheroid growth inhibition assay using HeLa cells.

Main Results:

• The octapeptide strongly binds to the GTP/GDP binding site of tubulin.
• It inhibits tubulin polymerization and reduces kinesin-driven microtubule motility.
• The peptide activates apoptotic and mitotic checkpoint proteins.
• It induces apoptotic cell death and significantly inhibits HeLa multicellular tumor spheroid growth.

Conclusions:

• The discovered octapeptide is a potent antimitotic agent.
• Its mechanism involves direct interaction with tubulin, leading to cell cycle arrest and apoptosis.
• The peptide demonstrates significant anti-tumor activity in a relevant in vitro model, suggesting therapeutic potential.